LONDON (Alliance News) - AstraZeneca PLC said Thursday that it will be presenting over 40 scientific abstracts to "demonstrate the rapid progression of its oncology pipeline" at the 50th Annual Meeting of the American Society of Clinical Ongology at the end of May. It will present data from Read More
LONDON (Alliance News) - Ligand Pharmaceuticals Inc Wednesday said it has signed a research and licensing agreement with AstraZeneca PLC's unit Omthera Pharmaceuticals, Inc. to develop products for treatment of dyslipidemia - a condition resulting from abnormal amount of lipids in the blood, as w Read More
LONDON (Alliance News) - Chief Executive of US drugs maker Pfizer Ian Read hit back at suggestions that a potential takeover of FTSE 100 listed AstraZeneca PLC could lead to delays in its products Wednesday, as the two companies faced a second day of hearings with UK politicians. Read and A Read More
LONDON (Alliance News) - <strong>ITV</strong> said Wednesday that first quarter revenue rose thanks to a continued recovery in advertising revenue, and said it expects to get a further boost from its coverage of the football World Cup in June as well as the launch of new TV channels.<br /><br Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br />COMPANIES<br />----------<br /><br />UK television company <strong>ITV PLC</strong> reported higher revenue for the first quarter of 2014 thanks to a continued recovery in advertising revenu Read More
LONDON (Alliance News) - Share have opened mixed in London Wednesday, with the FTSE 100 underperforming small- and mid-cap indices, ahead of UK economic data and announcements by the Bank of England.<br /><br />The blue-chip index is being weighed down by broadcaster <strong>ITV</strong>, whos Read More
LONDON (Alliance News) - British drugs giant AstraZeneca PLC, the subject of a GBP63 billion takeover approach from US rival Pfizer Inc, Wednesday said its MedImmune biologics arm would collaborate with Incyte Corp on an early-stage cancer treatment trial using a combination of the two companies' Read More
LONDON (Alliance News) - The FTSE 100 reached a fourteen-year high Tuesday as a dearth of fresh headlines out of Ukraine allowed investors to contemplate the potential for further monetary easing by central banks in China and Europe.<br /><br />Weak Chinese industrial production and retail sal Read More
LONDON (Alliance News) - UK pharmaceutical giant AstraZeneca PLC rejected Pfizer Inc's GBP63 billion approach again on Tuesday, calling it "opportunistic", but the company left the door open for an improved approach from its US rival. As UK politicians grilled executives of both companies a Read More
LONDON (Alliance News) - <strong>AstraZeneca</strong> Tuesday again rejected Pfizer's "opportunistic" GBP63 million takeover approach, as UK politicians grilled executives of both companies about the potential deal and what it will mean for the UK's pharmaceutical industry.<br /><br />Cruciall Read More
LONDON (Alliance News) - US equities are set to open higher Tuesday, following a record-breaking session on Monday, as investors await a raft of US macro-economic data releases. The DJIA and S&P 500 both ended the day at record highs Monday. The DJIA closed up 0.7% at 16,695.47, while the S Read More
LONDON (Alliance News) - AstraZeneca PLC Chief Executive Pascal Soriot, Pfizer Inc Chief Executive Ian Read, and representatives of trade unions Unite and GMB met with the House of Commons' Committee for Business, Innovation and Skills Tuesday to discuss the potential takeover of AstraZeneca by P Read More
LONDON (Alliance News) - AstraZeneca PLC hit back at US drugsmaker Pfizer Inc Tuesday, saying that it believes it is "making an opportunistic attempt to acquire a transformed AstraZeneca, without reflecting the value of its exciting pipeline." The company noted Pfizer's statement Tuesday re Read More
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>AstraZeneca</strong> PLC announced positive results from its late-stage study of combination treatment saxagliptin and dapagliflozin for Read More
LONDON (Alliance News) - AstraZeneca PLC Tuesday announced positive results from its late-stage study of combination treatment saxagliptin and dapagliflozin for the treatment of type 2 diabetes, for patients whose condition was no adequately controlled by the generic diabetes drug metformin. < Read More
LONDON (Alliance News) - Mid-cap stocks are leading London equities higher at the open Tuesday, following a strong lead in from the US and Asia, particularly Tokyo.<br /><br /><strong>Taylor Wimpey</strong> is leading the mid-cap FTSE 250, up 5.7%, after saying it expects to deliver a big incr Read More
LONDON (Alliance News) - UK stocks are expected to continue their push higher Tuesday, as investors take their cues from another strong close on Wall Street on Monday and a largely positive Asian session overnight. Following a firmly positive close in Europe on Monday, US stocks pushed sign Read More
LONDON (Alliance News) - US pharmaceutical giant Pfizer Inc. is planning to raise its bid for British rival AstraZeneca PLC a second time before it considers whether to make a hostile bid, Bloomberg reported Monday, citing people with knowledge of the matter. According to the Bloomberg repo Read More
LONDON (Alliance News) - AstraZeneca PLC Monday announced a flurry of positive data from mid-stage trials from its biological research and development arm MedImmune's respiratory, inflammation and autoimmune portfolio. Both rheumatoid arthritis treatment mavrilimumab and lupus treatment sif Read More
(An item published at 1221 GMT misstated the day of the evidence hearing. The correction version follows.) LONDON (Alliance News) - US drugmaker Pfizer Inc continued its campaign to buy FTSE 100 drugmaker AstraZeneca PLC Monday, submitting a statement to the UK House of Commons. Pfize Read More